WithdrawnNCT01495156
Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania
Medication studyAges 12–18United StatesBipolarity
Understand this study
Who could participate?
Listed age limits: 12 years to 18 years.
- Listed locations
- Glen OaksSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateSeptember 2011
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Northwell Health
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 12 Years to 18 Years
- Official registry ID
- NCT01495156
- Official title
Show the full official title
A Randomized, Double-blind, Placebo Controlled Study of the Efficacy of Adjunctive Lithium for the Treatment of Psychotic Mania Followed by an Open Label Long-term Safety Period.
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Glen Oaks
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Northwell Health.
Does this study involve medication?
Yes. The study involves medication, including Lithium treatment in combination with a SGA (Second Generation Antipsychotic) and Placebo/Adjunctive SGA treatment.
Who can participate?
Listed age limits: 12 years to 18 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
